Redcare Pharmacy Forecast, price target & analysts
Redcare Pharmacy Target price 2025 - Analyst rating & recommendation
Redcare Pharmacy Classifications & Recommendation:
Redcare Pharmacy Price Target
| Target Price | €168.54 |
| Price | €120.10 |
| Potential |
40.33%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Redcare Pharmacy 2026 .
The average Redcare Pharmacy target price is €168.54.
This is
40.33%
register free of charge
€214.00
78.18%
register free of charge
€93.00
22.56%
register free of charge
|
|
| A rating was issued by 13 analysts: 10 Analysts recommend Redcare Pharmacy to buy, 2 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Redcare Pharmacy stock has an average upside potential 2026 of
40.33%
register free of charge
|
Sales and Margin forecast 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Revenue Billion € | 1.80 | 2.37 |
| 49.36% | 31.86% | |
| EBITDA Margin | 2.25% | 1.54% |
| 276.87% | 31.69% | |
| Net Margin | -0.70% | -1.66% |
| 90.24% | 136.74% |
10 Analysts have issued a sales forecast Redcare Pharmacy 2024 . The average Redcare Pharmacy sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Redcare Pharmacy EBITDA forecast 2024. The average Redcare Pharmacy EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
10 Redcare Pharmacy Analysts have issued a net profit forecast 2024. The average Redcare Pharmacy net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2029
| Dec '23 |
2024 Estimates |
|
|---|---|---|
| Earnings Per Share € | -0.63 | -1.97 |
| 85.42% | 212.70% | |
| P/E | negative | |
| EV/Sales | 1.17 |
10 Analysts have issued a Redcare Pharmacy forecast for earnings per share. The average Redcare Pharmacy EPS is
This results in the following potential growth metrics and future valuations:
Redcare Pharmacy...
Current Redcare Pharmacy Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| METZLER EQUITIES |
Locked
➜
Locked
|
Locked | Jan 03 2025 |
| HAUCK AUFHAEUSER INVESTMENT BANKING |
Locked
➜
Locked
|
Locked | Dec 18 2024 |
| BERENBERG |
Locked
➜
Locked
|
Locked | Nov 28 2024 |
| HSBC |
Locked
➜
Locked
|
Locked | Nov 24 2024 |
| STIFEL EUROPE |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Nov 05 2024 |
| BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Nov 04 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
METZLER EQUITIES:
Locked
➜
Locked
|
Jan 03 2025 |
|
Locked
HAUCK AUFHAEUSER INVESTMENT BANKING:
Locked
➜
Locked
|
Dec 18 2024 |
|
Locked
BERENBERG:
Locked
➜
Locked
|
Nov 28 2024 |
|
Locked
HSBC:
Locked
➜
Locked
|
Nov 24 2024 |
|
Locked
STIFEL EUROPE:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Nov 05 2024 |
|
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Nov 04 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
